secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001099800-26-000023
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences appoints Theodora Mistras as CFO, effective May 29, 2026
-----------------------------------------------------------------------------

- Theodora Mistras appointed CFO effective May 29, 2026, succeeding Scott Ullem (announced October transition).
- Compensation: $925K base salary, $2.013M sign-on bonus (pro-rata clawback within 24 months), $8M RSUs (vesting over 3 years).
- Mistras was previously CFO of Viatris (since March 2024) and held senior roles at Citigroup and Goldman Sachs in healthcare IB.
- She is eligible for severance of at least 1x base salary plus 1x target bonus, pro-rated bonus, and $50K outplacement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000109980026000023/0001099800-26-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000109980026000023/ew-20260502.htm
  HTML page:      https://secwatch.observer/filing/0001099800-26-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer